Passage Bio Inc
NASDAQ:PASG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
B
|
Bajaj Finance Ltd
BSE:500034
|
IN |
|
Lufax Holding Ltd
F:0VU0
|
CN |
|
O
|
Okinawa Electric Power Co Inc
OTC:OKEPF
|
JP |
|
Sunrise Energy Metals Ltd
ASX:SRL
|
AU |
|
C
|
Charles Schwab Corp
DUS:SWG
|
US |
|
S
|
Sunrise Energy Metals Ltd
OTC:SREMF
|
AU |
|
Century Aluminum Co
NASDAQ:CENX
|
US |
|
S
|
SPSoft Inc
KOSDAQ:443670
|
KR |
|
8
|
8x8 Inc
DUS:EGT
|
US |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
|
M
|
Merck KGaA
XMUN:MRK
|
DE |
|
O
|
Observe Medical ASA
OSE:OBSRV
|
NO |
|
M
|
Mota Engil SGPS SA
ELI:EGL
|
PT |
|
Airtel Africa PLC
LSE:AAF
|
UK |
Bankruptcy Probability
Passage Bio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Passage Bio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Passage Bio Inc
NASDAQ:PASG
|
11.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Passage Bio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Passage Bio Inc has no debt.
You can find a full breakdown on its Balance Sheet.